Methanex Corporation (MX.TO)
Vancouver, BC, CA
Methanex Corporation, established in 1968 and headquartered in Vancouver, Canada, stands as a leading global manufacturer and provider of methanol. Its extensive operations cover North America, the Asia Pacific region, Europe, and South America. Beyond its own manufacturing output, the company also procures methanol from other suppliers through a combination of long-term off-take agreements and spot market purchases. To support its worldwide distribution network, Methanex owns and leases a variety of storage and terminal facilities. Furthermore, it maintains and operates a significant fleet of roughly 30 ocean-going vessels. The corporation's primary clientele consists of chemical and petrochemical manufacturers.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.14% | -0.59% | -8.24% | +18.51% | +62.31% | +49.82% | +85.15% | +47.01% | +90.12% | +89.06% | +283.81% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | -1 |
| Buy | 4 | 0 |
| Hold | 4 | +1 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%-1.8% Q1'26: +6.8% (vs Q1'25)
-
EPS growth Chemicals: +11.7%-61.1% Q1'26: -111.8% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%+19.0% ★ Q1'26: +7.3% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%+12.9% ★ Q1'26: +8.6% (vs Q1'25)
-
ROIC Chemicals: +3.4%+5.8% ★ Q1'26: +3.4% (vs Q1'25)
-
Share dilution Chemicals: +0.0%+7.5% Q1'26: +14.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×3.79× Q1'26: 4.32× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2004 actual |
Dec 2005 actual |
Dec 2006 actual |
Dec 2007 actual |
Dec 2008 actual |
Dec 2009 actual |
Dec 2010 actual |
Dec 2011 actual |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 7 Rev. Ana. 4 EPS Ana. |
Dec 2027 6 Rev. Ana. 9 EPS Ana. |
Dec 2028 2 Rev. Ana. 4 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.72B
est: 1.63B (+5.7%)
|
1.66B
est: 1.67B (-0.5%)
|
2.11B
est: 1.78B (+18.2%)
|
2.27B
est: 1.69B (+33.8%)
|
2.31B
est: 2.46B (-5.9%)
|
1.20B
est: 1.16B (+3.3%)
|
1.97B
est: 2.02B (-2.8%)
|
2.61B
est: 2.64B (-1.2%)
|
2.67B
est: 2.78B (-3.7%)
|
3.02B
est: 3.10B (-2.4%)
|
3.22B
est: 3.29B (-2.1%)
|
2.23B
est: 3.22B (-30.9%)
|
2.00B
est: 2.64B (-24.2%)
|
3.06B
est: 3.71B (-17.5%)
|
3.93B
est: 5.29B (-25.6%)
|
2.78B
est: 3.74B (-25.5%)
|
2.65B
est: 3.15B (-15.9%)
|
4.41B
est: 5.54B (-20.3%)
|
4.31B
est: 5.76B (-25.2%)
|
3.72B
est: 2.62B (+42.1%)
|
3.72B
est: 3.77B (-1.4%)
|
3.65B
est: 3.69B (-0.9%)
|
4.70B
4.42B – 5.09B
+27.4% YoY
|
4.09B
3.67B – 4.45B
-12.9% YoY
|
4.16B
3.83B – 4.51B
+1.6% YoY
|
| EBITDA |
434.39M
est: 333.91M (+30.1%)
|
410.57M
est: 395.70M (+3.8%)
|
800.08M
est: 358.86M (+123.0%)
|
652.34M
est: 340.73M (+91.5%)
|
341.06M
est: 897.89M (-62.0%)
|
141.83M
est: 131.22M (+8.1%)
|
296.40M
est: 150.42M (+97.0%)
|
500.72M
est: 320.72M (+56.1%)
|
91.03M
est: 372.23M (-75.5%)
|
626.86M
est: -56.91M (+1,201.5%)
|
797.58M
est: 521.98M (+52.8%)
|
367.70M
est: 521.81M (-29.5%)
|
224.00M
est: 306.65M (-27.0%)
|
708.69M
est: 229.82M (+208.4%)
|
1.15B
est: 826.31M (+39.3%)
|
589.39M
est: 683.70M (-13.8%)
|
334.53M
est: 281.74M (+18.7%)
|
1.08B
est: 328.10M (+227.7%)
|
983.03M
est: 375.99M (+161.4%)
|
794.81M
est: 672.12M (+18.3%)
|
798.42M
est: 973.06M (-17.9%)
|
925.00M
est: 945.52M (-2.2%)
|
1.20B
1.13B – 1.30B
+27.4% YoY
|
1.05B
941.92M – 1.14B
-12.9% YoY
|
1.07B
982.66M – 1.16B
+1.6% YoY
|
| EBIT |
355.69M
est: 167.16M (+112.8%)
|
319.34M
est: 364.35M (-12.4%)
|
693.25M
est: 179.65M (+285.9%)
|
539.91M
est: 170.57M (+216.5%)
|
233.93M
est: 784.04M (-70.2%)
|
23.83M
est: 106.94M (-77.7%)
|
159.18M
est: 42.23M (+276.9%)
|
345.72M
est: 205.47M (+68.3%)
|
-58.38M
est: 362.02M (-116.1%)
|
503.53M
est: -53.01M (+1,049.9%)
|
705.97M
est: 487.11M (+44.9%)
|
289.70M
est: 506.83M (-42.8%)
|
52.56M
est: 190.96M (-72.5%)
|
565.84M
est: 46.60M (+1,114.2%)
|
829.62M
est: 616.56M (+34.6%)
|
245.27M
est: 597.30M (-58.9%)
|
-22.60M
est: 145.14M (-115.6%)
|
711.97M
est: 169.02M (+321.2%)
|
610.61M
est: 193.69M (+215.2%)
|
402.98M
est: 340.89M (+18.2%)
|
412.72M
est: 493.52M (-16.4%)
|
469.34M
est: 479.55M (-2.1%)
|
610.93M
575.46M – 661.81M
+27.4% YoY
|
532.00M
477.72M – 579.28M
-12.9% YoY
|
540.73M
498.39M – 587.16M
+1.6% YoY
|
| Net Income |
236.44M
est: 115.29M (+105.1%)
|
165.75M
est: 242.15M (-31.5%)
|
482.95M
est: 243.90M (+98.0%)
|
375.67M
est: 183.18M (+105.1%)
|
172.30M
est: 545.59M (-68.4%)
|
738.0K
est: 81.24M (-99.1%)
|
101.73M
est: 1.22M (+8,228.5%)
|
201.33M
est: 132.59M (+51.8%)
|
-68.11M
est: 211.79M (-132.2%)
|
329.17M
est: -75.99M (+533.1%)
|
454.61M
est: 345.75M (+31.5%)
|
200.62M
est: 330.66M (-39.3%)
|
-12.55M
est: 161.06M (-107.8%)
|
316.14M
est: -20.55M (+1,638.2%)
|
568.98M
est: 409.08M (+39.1%)
|
87.77M
est: 409.65M (-78.6%)
|
-125.33M
est: 67.24M (-286.4%)
|
482.36M
est: 78.30M (+516.0%)
|
353.83M
est: 89.73M (+294.3%)
|
174.14M
est: 106.43M (+63.6%)
|
163.99M
est: 259.24M (-36.7%)
|
81.27M
est: 216.58M (-62.5%)
|
661.94M
492.35M – 831.53M
+205.6% YoY
|
381.19M
169.38M – 585.22M
-42.4% YoY
|
348.43M
312.96M – 387.32M
-8.6% YoY
|
| SGA |
—
est: 59.40M (-100.0%)
|
—
est: 60.84M (-100.0%)
|
—
est: 65.12M (-100.0%)
|
—
est: 61.83M (-100.0%)
|
—
est: 89.79M (-100.0%)
|
—
est: 42.33M (-100.0%)
|
—
est: 73.87M (-100.0%)
|
—
est: 96.31M (-100.0%)
|
184.84M
est: 137.30M (+34.6%)
|
274.46M
est: 206.22M (+33.1%)
|
124.11M
est: 288.30M (-57.0%)
|
113.63M
est: 90.27M (+25.9%)
|
204.76M
est: 91.22M (+124.5%)
|
243.71M
est: 335.45M (-27.4%)
|
182.52M
est: 315.36M (-42.1%)
|
184.17M
est: 131.41M (+40.2%)
|
246.78M
est: 141.09M (+74.9%)
|
210.85M
est: 164.31M (+28.3%)
|
82.10M
est: 188.30M (-56.4%)
|
84.00M
est: 166.20M (-49.5%)
|
—
est: 243.93M (-100.0%)
|
832.07M
est: 233.80M (+255.9%)
|
297.86M
280.56M – 322.66M
+27.4% YoY
|
259.38M
232.91M – 282.43M
-12.9% YoY
|
263.63M
242.99M – 286.27M
+1.6% YoY
|
| EPS |
1.95
est: 1.71 (+14.3%)
|
1.41
est: 1.46 (-3.3%)
|
4.43
est: 3.66 (+20.9%)
|
3.69
est: 2.75 (+34.1%)
|
1.79
est: 1.95 (-8.3%)
|
0.01
est: 0.03 (-64.1%)
|
1.10
est: 1.01 (+8.5%)
|
2.16
est: 1.99 (+8.4%)
|
-0.73
est: 1.78 (-140.9%)
|
3.46
est: 4.86 (-28.8%)
|
4.79
est: 3.95 (+21.2%)
|
2.21
est: 1.25 (+76.5%)
|
-0.14
est: -0.44 (+68.3%)
|
3.64
est: 4.21 (-13.4%)
|
7.07
est: 7.96 (-11.2%)
|
1.15
est: 0.74 (+54.4%)
|
-1.65
est: -1.64 (-0.3%)
|
6.34
est: 5.99 (+5.8%)
|
4.95
est: 4.45 (+11.2%)
|
2.57
est: 1.58 (+62.7%)
|
2.43
est: 3.55 (-31.6%)
|
1.10
est: 3.01 (-63.5%)
|
8.89
6.78 – 11.45
+195.1% YoY
|
5.25
2.33 – 8.06
-40.9% YoY
|
4.80
4.31 – 5.33
-8.6% YoY
|
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-05-05 | Scotiabank | Sector Outperform | Sector Outperform | Maintain |
| 2026-05-01 | UBS | Buy | Buy | Maintain |
| 2026-04-22 | Scotiabank | Sector Outperform | Sector Outperform | Maintain |
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-27 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-26 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-25 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-22 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-21 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-20 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-19 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-15 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-14 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-13 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-12 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-11 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-08 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-07 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-06 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-05 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-04 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-01 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-30 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-29 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-24 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-23 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-22 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-21 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-20 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-17 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-16 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-15 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Richard W. Sumner | President, Chief Executive Officer & Director | 3M | male |
| Gustavo Parra | Senior Vice President of Manufacturing | 2M | male |
| Karine Delbarre | Senior Vice President of Global Marketing & Logistics | 2M | female |
| Dean Richardson | Senior Vice President of Finance & Chief Financial Officer | 1M | male |
| Kevin Maloney | Senior Vice President of Corporate Development | 1M | male |
| Bradley W. Boyd | Senior Vice President of Corporate Resources | 1M | male |
| Sarah Herriott | Director of Investor Relations | — | female |
| Greg Mackie | VP of Human Resources | — | male |
| Kevin Price | Senior Vice President, General Counsel & Corporate Secretary | — | male |
| Mark Allard | Senior Vice President of Low Carbon Solutions | — | male |
| Rawle Ramlochan | Plant Manager | — | — |
| Robert Winslow | Vice President of Investor Relations | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for MX.TO
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
